Substrate recognition and cleavage mechanism of the monkeypox virus core protease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40262633.
- Also identified by DOI 10.1038/s41586-025-09014-x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Poxviruses cause severe diseases, including smallpox and mpox, that pose major threats to human health. The poxvirus core protease (Core<sup>Pro</sup>) is essential for viral maturation and is highly conserved in poxviruses, making it an attractive antiviral target<sup>1</sup>. However, the structure of Core<sup>Pro</sup> remains unknown, hampering antiviral development. Here we determined the apo structure of monkeypox virus (MPXV) Core<sup>Pro</sup> and the structure of Core<sup>Pro</sup> in a complex with the inhibitor aloxistatin, a drug candidate for muscular dystrophy<sup>2</sup>. These structures show that Core<sup>Pro</sup> forms a homodimer that features a unique 'dancing couple' fold. The catalytic intermediate state of Core<sup>Pro</sup> was characterized by an aldehyde derivative from a natural substrate (I-G18). This derivative binds covalently to the catalytic Cys328, shifting the active site of the viral protease from a closed conformation in the apo form to a favourable open conformation upon substrate binding. On the basis of the Core<sup>Pro</sup>-I-G18 complex, we designed a series of peptidomimetic inhibitors with a nitrile warhead, which could covalently anchor with the catalytic Cys328. These compounds inhibit Core<sup>Pro</sup> with half-maximal inhibitory concentrations of 44.9-100.3 nM, and exhibit potent and broad anti-poxvirus activity. Our studies provide a basis for designing wide-spectrum inhibitors against poxvirus infections.
Medical subject headings
- Monkeypox virus
- Viral Proteases
- Viral Proteins